Hyperion Therapeutics Inc (NASDAQ:HPTX)

46.06
Delayed Data
As of Apr 17
 +0.16 / +0.35%
Today’s Change
20.23
Today|||52-Week Range
46.96
+91.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-29.4M-32.3M16.6M-6.3M
 
 
 
 
 
Depreciation69.0K15.0K3.3M5.1M
 
 
 
 
 
Total Other Cash Flow2.6M2.4M-26.2M39.0M
 
 
 
 
 
Funds From Operations-26.7M-29.8M-6.3M37.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.2M-1.3M-5.1M6.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-24.5M-28.5M-1.2M31.0M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-43.9M-29.0M
 
 
 
Decrease In Investments0.000.000.0028.7M
 
 
Capital Expenditures-8.0K-45.0K-1.1M-654.0K
 
 
 
 
 
Net Assets From Acquisitions 0.000.000.00-14.0M
 
 
Other Investing - Uses-4.0K-283.0K0.000.00
 
 
 
Other Investing - Sources0.00330.0K11.0M0.00
 
 
 
Net Cash Flow Investing-12.0K2.0K-34.1M-15.0M
 
 
 
 
 
 
FinancingShort Term Borrowings25.0M7.5M0.000.00
 
 
 
Long Term Borrowings0.0010.2M-1.1M18.0M
 
 
 
 
Long Term Debt Reduction0.000.00-4.3M-8.2M
 
 
 
Net Proceeds Stock Sale0.0053.6M65.1M2.6M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.00108.0K
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing25.0M71.4M59.6M12.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash439.0K42.8M24.4M28.6M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account